Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder

ClinicalTrials.gov ID: NCT01718483

Public ClinicalTrials.gov record NCT01718483. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 2:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The SPD489-343, Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-optimization Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to demonstrate the efficacy of SPD489 compared with placebo in adults (18 55 years of age inclusive) with moderate to severe Binge Eating Disorder at Visit 8 (Weeks 11 and 12) as measured by the number of binge days (defined as days during which at least 1 binge episode occurs) per week as assessed by clinical interview based on subject diary

Study identification

NCT ID
NCT01718483
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
383 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 26, 2012 (Actual)
Primary completion
Sep 25, 2013 (Actual)
Completion
Sep 25, 2013 (Actual)
Last update posted
Jun 8, 2021

2012 – 2013

United States locations

U.S. sites
43
U.S. states
25
U.S. cities
43
Facility City State ZIP Site status
Birmingham Research Group Birmingham Alabama 35216 —
Clinical Study Centers, LLC Little Rock Arkansas 72211 —
Trimed Clinical Trials Corona California 92880 —
Pharmacology Research Institute Encino California 91316 —
Pharmacology Research Institute Los Alamitos California 90720 —
Pacific Research Partners, LLC Oakland California 94812 —
Research Across America Santa Ana California 92705 —
Western Affiliated Research Institute, Inc. Denver Colorado 80209 —
Gulfcoast Clinical Research Fort Myers Florida 33912 —
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256 —
Fidelity Clinical Research, Inc. Lauderhill Florida 33319 —
Compass Research LLC Leesburg Florida 34748 —
Scientific Clinical Research Inc. North Miami Florida 33161 —
Uptown Research Institute Chicago Illinois 60640 —
Alexian Brothers Behavioral Health Hospital Hoffman Estates Illinois 60169 —
AMR Baber Research, Inc. Naperville Illinois 60563 —
Goldpoint Clinical Research, LLC Indianapolis Indiana 46260 —
Cypress Medical Research Center, LLC Wichita Kansas 67226 —
McLean Hospital Belmont Massachusetts 02478 —
St. Charles Psychiatric Associates/Midwest Research Group Saint Charles Missouri 63304 —
Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas Nevada 89128 —
Pacific Research for Research and Evaluation Albuquerque New Mexico 87102 —
Wake Research Associates, LLC Raleigh North Carolina 27612 —
Community Research Cincinnati Ohio 45227 —
Midwest Clinical Research Center, LLC Dayton Ohio 45417 —
North Star Medical Research Middleburg Heights Ohio 44130 —
IPS Research Company Oklahoma City Oklahoma 73103 —
Oregon Center for Clinical Investigations, Inc. Salem Oregon 97301 —
The Clinical Trials Center, LLC Jenkintown Pennsylvania 19046 —
Suburban Research Associates Media Pennsylvania 19063 —
Clinical Trials Research Services, LLC Pittsburgh Pennsylvania 15206 —
Radiant Research, Inc. Anderson South Carolina 29621 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119 —
Future Search Trials Austin Texas 78731 —
Futuresearch Trials of Dallas, L.P. Dallas Texas 75231 —
Grayline Clinical Drug Trials Wichita Falls Texas 76309 —
Radiant Research, Inc. Murray Utah 84123 —
Neuropsychiatric Associates, LLC Woodstock Vermont 05091 —
Charlottesville Medical Research Center, LLC Charlottesville Virginia 22911 —
Alliance Research Group Richmond Virginia 23230 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Dean Foundation for Health, Research and Educations, Inc. Middleton Wisconsin 53562 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01718483, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 8, 2021 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01718483 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →